Ultragenyx Pharmaceutical Inc.
RARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001515673
In the last 90 days, Ultragenyx Pharmaceutical Inc. insiders filed 0 open-market purchases and 5 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $3.55B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Ultragenyx Pharmaceutical Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 275
- +7 vs. Q1 2024
- Shares held
- 88.2M
- +8.49M (+10.7%) vs. Q1 2024
- Total value
- $3.63B
- −$93.9M (−2.5%) vs. Q1 2024
- New holders
- 47
- 117 more added
- Sold out
- 40
- 80 more reduced
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RARE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 311 | $3.55B |
| Q1 2026 | 298 | $2.05B |
| Q4 2025 | 288 | $2.16B |
| Q3 2025 | 303 | $2.87B |
| Q2 2025 | 311 | $3.42B |
| Q1 2025 | 301 | $3.25B |
| Q4 2024 | 314 | $3.68B |
| Q3 2024 | 302 | $4.83B |
| Q2 2024 | 275 | $3.63B |
| Q1 2024 | 270 | $3.73B |
| Q4 2023 | 237 | $3.84B |
| Q3 2023 | 221 | $2.52B |
| Q2 2023 | 243 | $3.21B |
| Q1 2023 | 230 | $2.76B |
| Q4 2022 | 228 | $3.15B |
| Q3 2022 | 233 | $2.81B |
| Q2 2022 | 225 | $4.03B |
| Q1 2022 | 240 | $4.87B |
| Q4 2021 | 235 | $5.69B |
| Q3 2021 | 223 | $6.01B |
| Q2 2021 | 242 | $6.24B |
| Q1 2021 | 255 | $7.73B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Ultragenyx Pharmaceutical Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −5,161−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −4,863−100.0% | Sold out |
| Utah Retirement Systems | 0 | $0 | 0.00% | −4,300−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −3,587−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −1,311−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −642−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −158−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −124−100.0% | Sold out |
| Sunbelt Securities, Inc. | 0 | $0 | 0.00% | −86−100.0% | Sold out |
| First PREMIER Bank | 0 | $0 | 0.00% | −53−100.0% | Sold out |
| Anfield Capital Management, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Riggs Asset Managment Co. Inc. | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Shell Asset Management Co | – | – | – | – | Not filed |